Advertisement
Screener

Johnson & Johnson (JNJ) Interest Expense

Johnson & Johnson Interest Expense

Johnson & Johnson (JNJ) reported Interest Expense of $155.00 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-01.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2024-05-01

  • Johnson & Johnson interest expense for the quarter ending 2024-03-31 was $155.00M, a 26.89% decline year-over-year.
  • Johnson & Johnson interest expense for the quarter ending 2023-12-31 was $151.00M, a 14.69% decline year-over-year.
  • Johnson & Johnson interest expense for the quarter ending 2023-10-01 was $192.00M, a 276.47% increase year-over-year.
  • Johnson & Johnson interest expense for the quarter ending 2023-07-02 was $346.00M, a 810.53% increase year-over-year.
  • Johnson & Johnson interest expense for fiscal 2023 was $772.00M, a 179.71% increase from fiscal 2023.
  • Johnson & Johnson interest expense for fiscal 2023 was $276.00M, a 50.82% increase from fiscal 2022.
  • Johnson & Johnson interest expense for fiscal 2022 was $183.00M, a 8.96% decline from fiscal 2021.
  • Johnson & Johnson interest expense for fiscal 2021 was $201.00M, a 36.79% decline from fiscal 2019.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2024-03-31$155.00M
10-Q · filed 2024-05-01
$306.00M
derived: sum of 2 quarters · filed 2024-05-01
$498.00M
derived: sum of 3 quarters · filed 2024-05-01
$844.00M
derived: sum of 4 quarters · filed 2024-05-01
2023-12-31$151.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
$343.00M
derived: sum of 2 quarters · filed 2024-02-16
$689.00M
derived: sum of 3 quarters · filed 2024-02-16
$772.00M
10-K · filed 2024-02-16
2023-10-01$192.00M
10-Q · filed 2023-10-27
$538.00M
derived: sum of 2 quarters · filed 2023-10-27
$621.00M
10-Q · filed 2023-10-27
$927.00M
derived: sum of 4 quarters · filed 2024-05-01
2023-07-02$346.00M
10-Q · filed 2023-07-31
$561.00M
10-Q · filed 2023-07-31
$735.00M
derived: sum of 3 quarters · filed 2024-05-01
$786.00M
derived: sum of 4 quarters · filed 2024-05-01
2023-04-02$212.00M
10-Q · filed 2024-05-01
$215.00M
10-Q · filed 2023-04-28
$389.00M
derived: sum of 2 quarters · filed 2024-05-01
$440.00M
derived: sum of 3 quarters · filed 2024-05-01
$478.00M
derived: sum of 4 quarters · filed 2024-05-01
2023-01-01$177.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
$228.00M
derived: sum of 2 quarters · filed 2024-02-16
$266.00M
derived: sum of 3 quarters · filed 2024-02-16
$276.00M
10-K · filed 2024-02-16
2022-10-02$51.00M
10-Q · filed 2023-10-27
$89.00M
derived: sum of 2 quarters · filed 2023-10-27
$99.00M
10-Q · filed 2023-10-27
$159.00M
derived: sum of 4 quarters · filed 2024-02-16
2022-07-03$38.00M
10-Q · filed 2023-07-31
$48.00M
10-Q · filed 2023-07-31
$108.00M
derived: sum of 3 quarters · filed 2024-02-16
$128.00M
derived: sum of 4 quarters · filed 2024-02-16
2022-04-03$10.00M
10-Q · filed 2023-04-28
$70.00M
derived: sum of 2 quarters · filed 2024-02-16
$90.00M
derived: sum of 3 quarters · filed 2024-02-16
$130.00M
derived: sum of 4 quarters · filed 2024-02-16
2022-01-02$60.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
$80.00M
derived: sum of 2 quarters · filed 2024-02-16
$120.00M
derived: sum of 3 quarters · filed 2024-02-16
$183.00M
10-K · filed 2024-02-16
2021-10-03$20.00M
10-Q · filed 2022-10-27
$60.00M
derived: sum of 2 quarters · filed 2022-10-27
$123.00M
10-Q · filed 2022-10-27
$210.00M
derived: sum of 4 quarters · filed 2023-02-16
2021-07-04$40.00M
10-Q · filed 2022-07-29
$103.00M
10-Q · filed 2022-07-29
$190.00M
derived: sum of 3 quarters · filed 2023-02-16
$234.00M
derived: sum of 4 quarters · filed 2023-02-16
2021-04-04$63.00M
10-Q · filed 2022-04-29
$150.00M
derived: sum of 2 quarters · filed 2023-02-16
$194.00M
derived: sum of 3 quarters · filed 2023-02-16
$239.00M
derived: sum of 4 quarters · filed 2023-02-16
2021-01-03$87.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$131.00M
derived: sum of 2 quarters · filed 2023-02-16
$176.00M
derived: sum of 3 quarters · filed 2023-02-16
$201.00M
10-K · filed 2023-02-16
2020-09-27$44.00M
10-Q · filed 2021-10-29
$89.00M
derived: sum of 2 quarters · filed 2021-10-29
$114.00M
10-Q · filed 2021-10-29
$199.00M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-28$45.00M
10-Q · filed 2021-07-29
$70.00M
10-Q · filed 2021-07-29
$155.00M
derived: sum of 3 quarters · filed 2022-02-17
$203.00M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-29$25.00M
10-Q · filed 2021-04-30
$110.00M
derived: sum of 2 quarters · filed 2022-02-17
$158.00M
derived: sum of 3 quarters · filed 2022-02-17
$241.00M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-29$85.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$133.00M
derived: sum of 2 quarters · filed 2022-02-17
$216.00M
derived: sum of 3 quarters · filed 2022-02-17
$318.00M
10-K · filed 2022-02-17
2019-09-29$48.00M
10-Q · filed 2020-10-23
$131.00M
derived: sum of 2 quarters · filed 2020-10-23
$233.00M
10-Q · filed 2020-10-23
$483.00M
derived: sum of 4 quarters · filed 2021-02-22
2019-06-30$83.00M
10-Q · filed 2020-07-24
$185.00M
10-Q · filed 2020-07-24
$435.00M
derived: sum of 3 quarters · filed 2021-02-22
$678.00M
derived: sum of 4 quarters · filed 2021-02-22
2019-03-31$102.00M
10-Q · filed 2020-04-29
$352.00M
derived: sum of 2 quarters · filed 2021-02-22
$595.00M
derived: sum of 3 quarters · filed 2021-02-22
$848.00M
derived: sum of 4 quarters · filed 2021-02-22
2018-12-30$250.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22
$493.00M
derived: sum of 2 quarters · filed 2021-02-22
$746.00M
derived: sum of 3 quarters · filed 2021-02-22
$1.00B
10-K · filed 2021-02-22
2018-09-30$243.00M
10-Q · filed 2019-10-28
$496.00M
derived: sum of 2 quarters · filed 2019-10-28
$755.00M
10-Q · filed 2019-10-28
$1.03B
derived: sum of 4 quarters · filed 2020-02-18
2018-07-01$253.00M
10-Q · filed 2019-07-29
$512.00M
10-Q · filed 2019-07-29
$786.00M
derived: sum of 3 quarters · filed 2020-02-18
$1.01B
derived: sum of 4 quarters · filed 2020-02-18
2018-04-01$259.00M
10-Q · filed 2019-05-01
$533.00M
derived: sum of 2 quarters · filed 2020-02-18
$762.00M
derived: sum of 3 quarters · filed 2020-02-18
$989.00M
derived: sum of 4 quarters · filed 2020-02-18
2017-12-31$274.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18
$503.00M
derived: sum of 2 quarters · filed 2020-02-18
$730.00M
derived: sum of 3 quarters · filed 2020-02-18
$934.00M
10-K · filed 2020-02-18
2017-10-01$229.00M
10-Q · filed 2018-10-31
$456.00M
derived: sum of 2 quarters · filed 2018-10-31
$660.00M
10-Q · filed 2018-10-31
$844.00M
derived: sum of 4 quarters · filed 2019-02-20
2017-07-02$227.00M
10-Q · filed 2018-08-02
$431.00M
10-Q · filed 2018-08-02
$615.00M
derived: sum of 3 quarters · filed 2019-02-20
$807.00M
derived: sum of 4 quarters · filed 2019-02-20
2017-04-02$204.00M
10-Q · filed 2018-05-01
$388.00M
derived: sum of 2 quarters · filed 2019-02-20
$580.00M
derived: sum of 3 quarters · filed 2019-02-20
$770.00M
derived: sum of 4 quarters · filed 2019-02-20
2017-01-01$184.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
$376.00M
derived: sum of 2 quarters · filed 2019-02-20
$566.00M
derived: sum of 3 quarters · filed 2019-02-20
$726.00M
10-K · filed 2019-02-20
2016-10-02$192.00M
10-Q · filed 2017-11-02
$382.00M
derived: sum of 2 quarters · filed 2017-11-02
$542.00M
10-Q · filed 2017-11-02
$702.00M
derived: sum of 4 quarters · filed 2018-02-21
2016-07-03$190.00M
10-Q · filed 2017-08-03
$350.00M
10-Q · filed 2017-08-03
$510.00M
derived: sum of 3 quarters · filed 2018-02-21
$633.00M
derived: sum of 4 quarters · filed 2018-02-21
2016-04-03$160.00M
10-Q · filed 2017-05-08
$320.00M
derived: sum of 2 quarters · filed 2018-02-21
$443.00M
derived: sum of 3 quarters · filed 2018-02-21
$574.00M
derived: sum of 4 quarters · filed 2018-02-21
2016-01-03$160.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21
$283.00M
derived: sum of 2 quarters · filed 2018-02-21
$414.00M
derived: sum of 3 quarters · filed 2018-02-21
$552.00M
10-K · filed 2018-02-21
2015-09-27$123.00M
10-Q · filed 2016-11-04
$254.00M
derived: sum of 2 quarters · filed 2016-11-04
$392.00M
10-Q · filed 2016-11-04
$531.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-28$131.00M
10-Q · filed 2016-08-04
$269.00M
10-Q · filed 2016-08-04
$408.00M
derived: sum of 3 quarters · filed 2017-02-27
$538.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-29$138.00M
10-Q · filed 2016-05-10
$277.00M
derived: sum of 2 quarters · filed 2017-02-27
$407.00M
derived: sum of 3 quarters · filed 2017-02-27
$535.00M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-28$139.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$269.00M
derived: sum of 2 quarters · filed 2017-02-27
$397.00M
derived: sum of 3 quarters · filed 2017-02-27
$533.00M
10-K · filed 2017-02-27
2014-09-28$130.00M
10-Q · filed 2015-10-30
$258.00M
derived: sum of 2 quarters · filed 2015-10-30
$394.00M
10-Q · filed 2015-10-30
$528.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-29$128.00M
10-Q · filed 2015-07-31
$264.00M
10-Q · filed 2015-07-31
$398.00M
derived: sum of 3 quarters · filed 2016-02-24
$503.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-30$136.00M
10-Q · filed 2015-05-01
$270.00M
derived: sum of 2 quarters · filed 2016-02-24
$375.00M
derived: sum of 3 quarters · filed 2016-02-24
$493.00M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-29$134.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
$239.00M
derived: sum of 2 quarters · filed 2016-02-24
$357.00M
derived: sum of 3 quarters · filed 2016-02-24
$482.00M
10-K · filed 2016-02-24
2013-09-29$105.00M
10-Q · filed 2014-10-30
$223.00M
derived: sum of 2 quarters · filed 2014-10-30
$348.00M
10-Q · filed 2014-10-30
$455.00M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$118.00M
10-Q · filed 2014-08-01
$243.00M
10-Q · filed 2014-08-01
$350.00M
derived: sum of 3 quarters · filed 2015-02-24
$485.00M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$125.00M
10-Q · filed 2014-05-02
$232.00M
derived: sum of 2 quarters · filed 2015-02-24
$367.00M
derived: sum of 3 quarters · filed 2015-02-24
$510.00M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-30$107.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$242.00M
derived: sum of 2 quarters · filed 2015-02-24
$385.00M
derived: sum of 3 quarters · filed 2015-02-24
$532.00M
10-K · filed 2015-02-24
2012-09-30$135.00M
10-Q · filed 2013-11-04
$278.00M
derived: sum of 2 quarters · filed 2013-11-04
$425.00M
10-Q · filed 2013-11-04
$608.00M
derived: sum of 4 quarters · filed 2014-02-21
2012-07-01$143.00M
10-Q · filed 2013-08-01
$290.00M
10-Q · filed 2013-08-01
$473.00M
derived: sum of 3 quarters · filed 2014-02-21
$607.00M
derived: sum of 4 quarters · filed 2014-02-21
2012-04-01$147.00M
10-Q · filed 2013-05-03
$330.00M
derived: sum of 2 quarters · filed 2014-02-21
$464.00M
derived: sum of 3 quarters · filed 2014-02-21
$593.00M
derived: sum of 4 quarters · filed 2014-02-21
2012-01-01$183.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21
$317.00M
derived: sum of 2 quarters · filed 2014-02-21
$446.00M
derived: sum of 3 quarters · filed 2014-02-21
$571.00M
10-K · filed 2014-02-21
2011-10-02$134.00M
10-Q · filed 2012-11-09
$263.00M
derived: sum of 2 quarters · filed 2012-11-09
$388.00M
10-Q · filed 2012-11-09
$526.00M
derived: sum of 4 quarters · filed 2013-02-22
2011-07-03$129.00M
10-Q · filed 2012-08-02
$254.00M
10-Q · filed 2012-08-02
$392.00M
derived: sum of 3 quarters · filed 2013-02-22
$500.00M
derived: sum of 4 quarters · filed 2013-02-22
2011-04-03$125.00M
10-Q · filed 2012-05-07
$263.00M
derived: sum of 2 quarters · filed 2013-02-22
$371.00M
derived: sum of 3 quarters · filed 2013-02-22
$472.00M
derived: sum of 4 quarters · filed 2013-02-22
2011-01-02$138.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$246.00M
derived: sum of 2 quarters · filed 2013-02-22
$347.00M
derived: sum of 3 quarters · filed 2013-02-22
$455.00M
10-K · filed 2013-02-22
2010-10-03$108.00M
10-Q · filed 2011-11-08
$209.00M
derived: sum of 2 quarters · filed 2011-11-08
$317.00M
10-Q · filed 2011-11-08
$410.00M
derived: sum of 4 quarters · filed 2012-02-23
2010-07-04$101.00M
10-Q · filed 2011-08-09
$209.00M
10-Q · filed 2011-08-09
$302.00M
derived: sum of 3 quarters · filed 2012-02-23
$444.00M
derived: sum of 4 quarters · filed 2012-02-23
2010-04-04$108.00M
10-Q · filed 2011-05-10
$201.00M
derived: sum of 2 quarters · filed 2012-02-23
$343.00M
derived: sum of 3 quarters · filed 2012-02-23
$453.00M
derived: sum of 4 quarters · filed 2012-02-23
2010-01-03$93.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23
$235.00M
derived: sum of 2 quarters · filed 2012-02-23
$345.00M
derived: sum of 3 quarters · filed 2012-02-23
$451.00M
10-K · filed 2012-02-23
2009-09-27$142.00M
10-Q · filed 2010-11-10
$252.00M
derived: sum of 2 quarters · filed 2010-11-10
$358.00M
10-Q · filed 2010-11-10
$468.00M
derived: sum of 4 quarters · filed 2011-02-25
2009-06-28$110.00M
10-Q · filed 2010-08-11
$216.00M
10-Q · filed 2010-08-11
$326.00M
derived: sum of 3 quarters · filed 2011-02-25
$448.00M
derived: sum of 4 quarters · filed 2011-02-25
2009-03-29$106.00M
10-Q · filed 2010-05-10
$216.00M
derived: sum of 2 quarters · filed 2011-02-25
$338.00M
derived: sum of 3 quarters · filed 2011-02-25
$443.00M
derived: sum of 4 quarters · filed 2011-02-25
2008-12-28$110.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25
$232.00M
derived: sum of 2 quarters · filed 2011-02-25
$337.00M
derived: sum of 3 quarters · filed 2011-02-25
$435.00M
10-K · filed 2011-02-25
2008-09-28$122.00M
10-Q · filed 2009-11-04
$227.00M
derived: sum of 2 quarters · filed 2009-11-04
$325.00M
10-Q · filed 2009-11-04
2008-06-29$105.00M
10-Q · filed 2009-08-04
$203.00M
10-Q · filed 2009-08-04
2007-12-30$296.00M
10-K · filed 2010-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38